JP2020073472A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020073472A5 JP2020073472A5 JP2019179190A JP2019179190A JP2020073472A5 JP 2020073472 A5 JP2020073472 A5 JP 2020073472A5 JP 2019179190 A JP2019179190 A JP 2019179190A JP 2019179190 A JP2019179190 A JP 2019179190A JP 2020073472 A5 JP2020073472 A5 JP 2020073472A5
- Authority
- JP
- Japan
- Prior art keywords
- conjugate
- substituted
- linker
- covalently bonded
- appropriately substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims 3
- 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 2
- 235000001014 amino acid Nutrition 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 235000003704 aspartic acid Nutrition 0.000 claims 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 2
- 239000003446 ligand Substances 0.000 claims 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 2
- 150000002993 phenylalanine derivatives Chemical class 0.000 claims 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 2
- 150000003667 tyrosine derivatives Chemical class 0.000 claims 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- WDLRUFUQRNWCPK-UHFFFAOYSA-N Tetraxetan Chemical group OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1 WDLRUFUQRNWCPK-UHFFFAOYSA-N 0.000 claims 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 1
- 239000004473 Threonine Substances 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 235000009697 arginine Nutrition 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 239000004202 carbamide Substances 0.000 claims 1
- 239000013522 chelant Substances 0.000 claims 1
- 239000002738 chelating agent Substances 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 1
- 235000004554 glutamine Nutrition 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 235000018977 lysine Nutrition 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 229960003104 ornithine Drugs 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000002285 radioactive effect Effects 0.000 claims 1
- -1 urea compound Chemical class 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95648907P | 2007-08-17 | 2007-08-17 | |
| US60/956,489 | 2007-08-17 | ||
| US7435808P | 2008-06-20 | 2008-06-20 | |
| US61/074,358 | 2008-06-20 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017223872A Division JP6596479B2 (ja) | 2007-08-17 | 2017-11-21 | Ｐｓｍａ結合性リガンド−リンカー結合体及び使用方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021019732A Division JP7079355B2 (ja) | 2007-08-17 | 2021-02-10 | Ｐｓｍａ結合性リガンド－リンカー結合体及び使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020073472A JP2020073472A (ja) | 2020-05-14 |
| JP2020073472A5 true JP2020073472A5 (enExample) | 2020-09-10 |
| JP6838118B2 JP6838118B2 (ja) | 2021-03-03 |
Family
ID=40378553
Family Applications (9)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010521210A Pending JP2010536790A (ja) | 2007-08-17 | 2008-08-15 | Ｐｓｍａ結合性リガンド−リンカー結合体及び使用方法 |
| JP2014125603A Active JP5902237B2 (ja) | 2007-08-17 | 2014-06-18 | Ｐｓｍａ結合性リガンド−リンカー結合体及び使用方法 |
| JP2016046076A Pending JP2016153410A (ja) | 2007-08-17 | 2016-03-09 | Ｐｓｍａ結合性リガンド−リンカー結合体及び使用方法 |
| JP2017223872A Active JP6596479B2 (ja) | 2007-08-17 | 2017-11-21 | Ｐｓｍａ結合性リガンド−リンカー結合体及び使用方法 |
| JP2018100343A Active JP6625690B2 (ja) | 2007-08-17 | 2018-05-25 | Ｐｓｍａ結合性リガンド−リンカー結合体及び使用方法 |
| JP2019179190A Active JP6838118B2 (ja) | 2007-08-17 | 2019-09-30 | Ｐｓｍａ結合性リガンド−リンカー結合体及び使用方法 |
| JP2021019732A Active JP7079355B2 (ja) | 2007-08-17 | 2021-02-10 | Ｐｓｍａ結合性リガンド－リンカー結合体及び使用方法 |
| JP2022082105A Active JP7609824B2 (ja) | 2007-08-17 | 2022-05-19 | Ｐｓｍａ結合性リガンド－リンカー結合体及び使用方法 |
| JP2024095014A Pending JP2024117783A (ja) | 2007-08-17 | 2024-06-12 | Ｐｓｍａ結合性リガンド－リンカー結合体及び使用方法 |
Family Applications Before (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010521210A Pending JP2010536790A (ja) | 2007-08-17 | 2008-08-15 | Ｐｓｍａ結合性リガンド−リンカー結合体及び使用方法 |
| JP2014125603A Active JP5902237B2 (ja) | 2007-08-17 | 2014-06-18 | Ｐｓｍａ結合性リガンド−リンカー結合体及び使用方法 |
| JP2016046076A Pending JP2016153410A (ja) | 2007-08-17 | 2016-03-09 | Ｐｓｍａ結合性リガンド−リンカー結合体及び使用方法 |
| JP2017223872A Active JP6596479B2 (ja) | 2007-08-17 | 2017-11-21 | Ｐｓｍａ結合性リガンド−リンカー結合体及び使用方法 |
| JP2018100343A Active JP6625690B2 (ja) | 2007-08-17 | 2018-05-25 | Ｐｓｍａ結合性リガンド−リンカー結合体及び使用方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021019732A Active JP7079355B2 (ja) | 2007-08-17 | 2021-02-10 | Ｐｓｍａ結合性リガンド－リンカー結合体及び使用方法 |
| JP2022082105A Active JP7609824B2 (ja) | 2007-08-17 | 2022-05-19 | Ｐｓｍａ結合性リガンド－リンカー結合体及び使用方法 |
| JP2024095014A Pending JP2024117783A (ja) | 2007-08-17 | 2024-06-12 | Ｐｓｍａ結合性リガンド－リンカー結合体及び使用方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (25) | US9193763B2 (enExample) |
| EP (7) | EP2187965B1 (enExample) |
| JP (9) | JP2010536790A (enExample) |
| CN (2) | CN104873982A (enExample) |
| AU (1) | AU2008289108C1 (enExample) |
| CA (1) | CA2696627C (enExample) |
| DK (1) | DK2187965T3 (enExample) |
| ES (1) | ES2768224T3 (enExample) |
| HK (1) | HK1212588A1 (enExample) |
| HU (1) | HUE047200T2 (enExample) |
| IL (1) | IL203998A (enExample) |
| NZ (2) | NZ583931A (enExample) |
| PL (1) | PL2187965T3 (enExample) |
| PT (1) | PT2187965T (enExample) |
| SI (1) | SI2187965T1 (enExample) |
| WO (1) | WO2009026177A1 (enExample) |
Families Citing this family (131)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1390077B1 (en) | 2001-05-02 | 2014-07-16 | Purdue Research Foundation | Treatment and diagnosis of macrophage mediated disease |
| US8043603B2 (en) | 2002-02-07 | 2011-10-25 | Endocyte, Inc. | Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology |
| US8043602B2 (en) | 2002-02-07 | 2011-10-25 | Endocyte, Inc. | Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology |
| JP4680185B2 (ja) | 2003-05-30 | 2011-05-11 | パーデュー・リサーチ・ファウンデーション | アテローム性動脈硬化症の診断法 |
| WO2006012527A1 (en) | 2004-07-23 | 2006-02-02 | Endocyte, Inc. | Bivalent linkers and conjugates thereof |
| EP1904183B1 (en) | 2005-07-05 | 2014-10-15 | Purdue Research Foundation | Pharmaceutical composition for the treatment of osteoarthritis |
| EP1940473A2 (en) | 2005-09-23 | 2008-07-09 | Purdue Research Foundation | Multiphoton in vivo flow cytometry method and device |
| JP2010509570A (ja) | 2006-11-03 | 2010-03-25 | パーデュー・リサーチ・ファウンデーション | エクスビボフローサイトメトリーの方法および装置 |
| DK2097111T3 (en) * | 2006-11-08 | 2015-08-24 | Molecular Insight Pharm Inc | Heterodimers of glutamic acid |
| AU2008213702B2 (en) | 2007-02-07 | 2014-04-24 | Purdue Research Foundation | Positron emission tomography imaging method |
| AU2008224988A1 (en) | 2007-03-14 | 2008-09-18 | Endocyte, Inc. | Binding ligand linked drug delivery conjugates of tubulysins |
| CA2688308A1 (en) | 2007-05-25 | 2008-12-04 | Purdue Research Foundation | Method of imaging localized infections |
| RU2523909C2 (ru) | 2007-06-25 | 2014-07-27 | Эндосайт, Инк. | Конъюгаты, содержащие гидрофильные спейсеры линкеров |
| US9877965B2 (en) | 2007-06-25 | 2018-01-30 | Endocyte, Inc. | Vitamin receptor drug delivery conjugates for treating inflammation |
| GB0718967D0 (en) * | 2007-09-28 | 2007-11-07 | Ge Healthcare Ltd | Peptide imaging agents |
| PT2187965T (pt) | 2007-08-17 | 2020-01-17 | Purdue Research Foundation | Conjugados ligando-ligante de ligação a psma e métodos para utilização |
| US8852630B2 (en) * | 2008-05-13 | 2014-10-07 | Yale University | Chimeric small molecules for the recruitment of antibodies to cancer cells |
| JP5746615B2 (ja) * | 2008-05-13 | 2015-07-08 | エール ユニヴァーシティ | 癌細胞への抗体の動員のためのキメラ小分子 |
| HRP20240952T1 (hr) * | 2009-03-19 | 2024-10-11 | The Johns Hopkins University | Spojevi koji ciljaju psma i njihova uporaba |
| US20180009767A9 (en) | 2009-03-19 | 2018-01-11 | The Johns Hopkins University | Psma targeted fluorescent agents for image guided surgery |
| AU2010249719A1 (en) | 2009-05-19 | 2012-05-31 | Aic Blab Company | Composite current collector and methods therefor |
| US8394922B2 (en) | 2009-08-03 | 2013-03-12 | Medarex, Inc. | Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
| US12083191B2 (en) | 2009-10-19 | 2024-09-10 | Case Western Reserve University | Composition and methods for imaging cells |
| WO2011106639A1 (en) * | 2010-02-25 | 2011-09-01 | Purdue Research Foundation | Psma binding ligand-linker conjugates and methods for using |
| US9951324B2 (en) | 2010-02-25 | 2018-04-24 | Purdue Research Foundation | PSMA binding ligand-linker conjugates and methods for using |
| US10363309B2 (en) | 2011-02-04 | 2019-07-30 | Case Western Reserve University | Targeted nanoparticle conjugates |
| MX2013014583A (es) | 2011-06-10 | 2014-03-31 | Mersana Therapeutics Inc | Conjugados de proteina-polimero-farmaco. |
| CN103930432B (zh) | 2011-06-15 | 2017-06-23 | 癌靶技术有限责任公司 | 螯合的psma抑制剂 |
| US8784774B2 (en) | 2011-09-16 | 2014-07-22 | General Electric Company | Labeled molecular imaging agents and methods of use |
| US20130116404A1 (en) | 2011-11-08 | 2013-05-09 | Case Western Reserve University | Targeted non-invasive imaging probes of egfr expressing cells |
| US10080805B2 (en) | 2012-02-24 | 2018-09-25 | Purdue Research Foundation | Cholecystokinin B receptor targeting for imaging and therapy |
| US20140080175A1 (en) | 2012-03-29 | 2014-03-20 | Endocyte, Inc. | Processes for preparing tubulysin derivatives and conjugates thereof |
| US10501412B2 (en) | 2012-07-12 | 2019-12-10 | Hangzhou Dac Biotech Co., Ltd. | Conjugates of cell binding molecules with cytotoxic agents |
| US20140081659A1 (en) | 2012-09-17 | 2014-03-20 | Depuy Orthopaedics, Inc. | Systems and methods for surgical and interventional planning, support, post-operative follow-up, and functional recovery tracking |
| WO2014062697A2 (en) | 2012-10-16 | 2014-04-24 | Endocyte, Inc. | Drug delivery conjugates containing unnatural amino acids and methods for using |
| JP6892218B2 (ja) | 2012-11-15 | 2021-06-23 | エンドサイト・インコーポレイテッドＥｎｄｏｃｙｔｅ， Ｉｎｃ． | 薬物送達結合体およびｐｓｍａ発現細胞によって引き起こされる疾患の治療方法 |
| JP6133431B2 (ja) | 2012-11-24 | 2017-05-24 | ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． | 親水性連結体及び薬物分子と細胞結合分子との共役反応における親水性連結体の使用 |
| JP6334553B2 (ja) | 2012-12-10 | 2018-05-30 | メルサナ セラピューティクス，インコーポレイティド | タンパク質−高分子−薬剤コンジュゲート |
| EP2931316B1 (en) | 2012-12-12 | 2019-02-20 | Mersana Therapeutics, Inc. | Hydroxyl-polymer-drug-protein conjugates |
| KR102215954B1 (ko) | 2013-02-14 | 2021-02-15 | 브리스톨-마이어스 스큅 컴퍼니 | 튜부리신 화합물, 그의 제조 및 사용 방법 |
| US11975074B2 (en) | 2013-02-15 | 2024-05-07 | Case Western Reserve University | Photodynamic therapy composition |
| WO2014127365A1 (en) * | 2013-02-15 | 2014-08-21 | Case Western Reserve University | Psma ligands and uses thereof |
| US12465651B2 (en) | 2013-02-15 | 2025-11-11 | Case Western Reserve University | Photodynamic therapy composition |
| US10207005B2 (en) | 2013-02-15 | 2019-02-19 | Case Western Reserve University | Photodynamic therapy composition |
| ES2790420T3 (es) * | 2013-03-14 | 2020-10-27 | Scripps Research Inst | Conjugados de anticuerpos y de agentes de focalización usos de los mismos |
| US10434194B2 (en) | 2013-06-20 | 2019-10-08 | Case Western Reserve University | PSMA targeted nanobubbles for diagnostic and therapeutic applications |
| WO2015057692A1 (en) * | 2013-10-14 | 2015-04-23 | The Johns Hopkins University | Prostate-specific membrane antigen-targeted photosensitizers for photodynamic therapy |
| JP6637415B2 (ja) * | 2013-10-15 | 2020-01-29 | ザ スクリプス リサーチ インスティテュート | キメラ抗原受容体ｔ細胞スイッチおよびその使用 |
| WO2015057834A1 (en) | 2013-10-15 | 2015-04-23 | The California Institute For Biomedical Research | Peptidic chimeric antigen receptor t cell switches and uses thereof |
| EP3415489A1 (en) | 2013-10-18 | 2018-12-19 | Deutsches Krebsforschungszentrum | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
| WO2015069766A1 (en) * | 2013-11-06 | 2015-05-14 | Purdue Research Foundation | Dupa-indenoisoquinoline conjugates |
| BR112016010927A2 (pt) * | 2013-11-14 | 2017-08-08 | Endocyte Inc | Conjugado de fórmula |
| US9468693B2 (en) | 2014-01-23 | 2016-10-18 | General Electric Company | Labeled molecular imaging agents and methods of use |
| US9468692B2 (en) | 2014-01-23 | 2016-10-18 | General Electric Company | Labeled molecular imaging agents and methods of use |
| CA2938919C (en) | 2014-02-28 | 2020-12-29 | Hangzhou Dac Biotech Co., Ltd | Charged linkers and their uses for conjugation |
| CA2950892C (en) | 2014-05-06 | 2023-10-24 | The Johns Hopkins University | Metal/radiometal-labeled psma inhibitors for psma-targeted imaging and radiotherapy |
| CN106687121A (zh) | 2014-05-14 | 2017-05-17 | 亚历克斯利维斯兹奇管理和控股有限公司 | 改善的聚乙烯亚胺聚乙二醇载体 |
| CN104262458B (zh) * | 2014-08-29 | 2017-02-01 | 邵国强 | 一种与psma膜外区靶向性结合的多肽、放射性核素标记多肽及其应用 |
| US20170226159A1 (en) * | 2014-09-26 | 2017-08-10 | Kaneka Corporation | Method for producing hydrophobic peptide |
| WO2016065142A2 (en) | 2014-10-22 | 2016-04-28 | The Johns Hopkins University | New scaffolds and multifunctional intermediates for imaging psma and cancer therapy |
| US10077287B2 (en) | 2014-11-10 | 2018-09-18 | Bristol-Myers Squibb Company | Tubulysin analogs and methods of making and use |
| US10188759B2 (en) | 2015-01-07 | 2019-01-29 | Endocyte, Inc. | Conjugates for imaging |
| IL237525A (en) | 2015-03-03 | 2017-05-29 | Shalom Eli | Method for labeling a prostate-specific membrane antigen with a radioactive isotope |
| US10800828B2 (en) | 2015-03-26 | 2020-10-13 | The Scripps Research Institute | Switchable non-scFv chimeric receptors, switches, and methods of use thereof to treat cancer |
| US11091546B2 (en) | 2015-04-15 | 2021-08-17 | The Scripps Research Institute | Optimized PNE-based chimeric receptor T cell switches and uses thereof |
| WO2016183131A1 (en) * | 2015-05-11 | 2016-11-17 | Purdue Research Foundation | Ligand ionophore conjugates |
| AU2015242213A1 (en) | 2015-07-12 | 2018-03-08 | Hangzhou Dac Biotech Co., Ltd | Bridge linkers for conjugation of cell-binding molecules |
| US9839687B2 (en) | 2015-07-15 | 2017-12-12 | Suzhou M-Conj Biotech Co., Ltd. | Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule |
| EP3334466B1 (en) | 2015-08-14 | 2020-05-13 | Endocyte, Inc. | Method of imaging with a chelating compound |
| US9808538B2 (en) * | 2015-09-09 | 2017-11-07 | On Target Laboratories, LLC | PSMA-targeted NIR dyes and their uses |
| US10842887B2 (en) | 2015-09-09 | 2020-11-24 | On Target Laboratories, LLC | PSMA-targeted NIR dyes and their uses |
| GEAP202014748A (en) * | 2015-09-30 | 2020-01-27 | Univ Heidelberg Ruprecht Karls | 18f-tagged inhibitors of prostate specific membrane antigen (psma) and their use as imaging agents for prostate cancer |
| CA3002774A1 (en) * | 2015-10-23 | 2017-04-27 | Sorrento Therapeutics, Inc. | Programmable universal cell receptors and methods of using the same |
| US10405753B2 (en) * | 2015-11-10 | 2019-09-10 | Intuitive Surgical Operations, Inc. | Pharmaceutical compositions of near IR closed chain, sulfo-cyanine dyes |
| US11793880B2 (en) | 2015-12-04 | 2023-10-24 | Seagen Inc. | Conjugates of quaternized tubulysin compounds |
| MX2018006218A (es) | 2015-12-04 | 2018-09-05 | Seattle Genetics Inc | Conjugados de compuestos de tubulisina cuaternizada. |
| US12252534B2 (en) | 2016-02-04 | 2025-03-18 | The Scripps Research Institute | Humanized anti-CD3 antibodies, conjugates and uses thereof |
| WO2017161170A1 (en) * | 2016-03-16 | 2017-09-21 | Purdue Research Foundation | Carbonic anhydrase ix targeting agents and methods |
| JP2019515880A (ja) | 2016-03-16 | 2019-06-13 | エンドサイト・インコーポレイテッドＥｎｄｏｃｙｔｅ， Ｉｎｃ． | 炭酸無水酵素ｉｘ阻害剤抱合体およびその使用 |
| US20170296679A1 (en) * | 2016-04-18 | 2017-10-19 | Intuitive Surgical Operations, Inc. | Compositions of Near IR Closed Chain, Sulfo-Cyanine Dyes and Prostate Specific Membrane Antigen Ligands |
| WO2018049132A1 (en) * | 2016-09-09 | 2018-03-15 | On Target Laboratories, LLC | Psma-targeted nir dyes and their uses |
| ES3030503T3 (en) | 2016-10-19 | 2025-06-30 | Scripps Research Inst | Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof |
| MX2019005583A (es) | 2016-11-14 | 2019-10-21 | Hangzhou Dac Biotech Co Ltd | Vinculantes de conjugacion, conjugados de molecula de union a celulas que contienen los vinculantes, metodos de creacion y usos de dichos conjugados con los vinculantes. |
| CN110167577B (zh) * | 2016-11-16 | 2024-05-10 | 普渡研究基金会 | 配体离子载体共轭物 |
| US20200237936A1 (en) | 2016-12-14 | 2020-07-30 | Purdue Research Foundation | Fibroblast activation protein (fap)-targeted imaging and therapy |
| KR102085798B1 (ko) | 2016-12-28 | 2020-03-06 | 주식회사 인투셀 | 베타-갈락토사이드가 도입된 자가-희생 기를 포함하는 화합물 |
| CN120571030A (zh) * | 2017-08-22 | 2025-09-02 | 普渡研究基金会 | 靶向碳酸酐酶阳性癌症的基于fbsa的治疗和放射性成像缀合物 |
| ES2943335T3 (es) * | 2017-09-22 | 2023-06-12 | Heidelberg Pharma Res Gmbh | Conjugados de amanitina dirigidos a PSMA |
| EP3723816A1 (en) | 2017-12-13 | 2020-10-21 | Sciencons AS | Complex comprising a psma-targeting compound linked to a lead or thorium radionuclide |
| KR20250126870A (ko) | 2018-02-06 | 2025-08-25 | 더 존스 홉킨스 유니버시티 | 암 방사선 치료를 위한 psma 표적 방사성 할로겐화 우레아-폴리아미노카복실레이트 |
| WO2019183633A1 (en) | 2018-03-23 | 2019-09-26 | Case Western Reserve Univeristy | Psma targeted conjugate compounds and uses thereof |
| US12208102B2 (en) | 2018-04-17 | 2025-01-28 | Endocyte, Inc. | Methods of treating cancer |
| WO2019246445A1 (en) * | 2018-06-20 | 2019-12-26 | The Research Foundation For The State University Of New York | Triazamacrocycle-derived chelator compositions for coordination of imaging and therapy metal ions and methods of using same |
| CN110922450B (zh) * | 2018-09-19 | 2021-11-02 | 薪火炙药(北京)科技有限公司 | Psma激活式抗肿瘤前药cpt-x及其制备方法和应用 |
| CN113166087B (zh) | 2018-09-21 | 2024-05-10 | 恩多塞特公司 | 屏蔽剂及其用途 |
| RU2697519C1 (ru) * | 2018-10-15 | 2019-08-15 | Общество с ограниченной ответственностью "Изварино Фарма" | Средство пептидной природы, включающее псма-связывающий лиганд на основе производного мочевины, способ его получения и применение для получения конъюгата с лекарственным и диагностическим агентом |
| WO2020108753A1 (en) * | 2018-11-28 | 2020-06-04 | ITM Isotopen Technologien München AG | Novel tumor antigen binding agents and uses thereof |
| EP3893942A4 (en) * | 2018-12-14 | 2022-12-14 | The Johns Hopkins University | Psma-targeted pamam dendrimers for specific delivery of imaging, contrast and therapeutic agents |
| WO2020150740A1 (en) * | 2019-01-18 | 2020-07-23 | Case Western Reserve University | Psma ligand targeted compounds and uses thereof |
| JP7421232B2 (ja) * | 2019-01-30 | 2024-01-24 | テクニシェ ユニバーシタット ミュンヘン | フッ化ケイ素アクセプタ置換放射性医薬品とその前駆体 |
| CN120097930A (zh) | 2019-05-20 | 2025-06-06 | 因多塞特股份有限公司 | 制备psma缀合物的方法 |
| CN110305186B (zh) * | 2019-06-06 | 2021-02-23 | 原子高科股份有限公司 | 前列腺癌PET诊断试剂68Ga-DOTA-ANCP-PSMA及其制备方法和应用 |
| CN110305187B (zh) * | 2019-06-06 | 2021-02-23 | 原子高科股份有限公司 | 前列腺癌PET诊断试剂68Ga-NOTA-ANCP-PSMA及其制备方法和应用 |
| US20230025327A1 (en) | 2019-06-29 | 2023-01-26 | Hangzhou Dac Biotech Co., Ltd. | Conjugates of tubulysin derivatives and cell binding molecules and methods of making |
| RU2713151C1 (ru) * | 2019-07-02 | 2020-02-04 | Общество с ограниченной ответственностью "Изварино Фарма" | Конъюгат флуоресцентного красителя с веществом пептидной природы, включающим псма-связывающий лиганд на основе производного мочевины для визуализации клеток, экспрессирующих псма, способ его получения и применения |
| BR112022000337A2 (pt) * | 2019-07-10 | 2022-04-12 | Cybrexa 2 Inc | Conjugados de peptídeos de citotoxinas como terapêuticos |
| AU2020311925A1 (en) | 2019-07-10 | 2022-02-03 | Cybrexa 3, Inc. | Peptide conjugates of microtubule-targeting agents as therapeutics |
| WO2021081430A1 (en) * | 2019-10-23 | 2021-04-29 | Collagen Medical, LLC | Fibrin-binding compounds for imaging and treatment |
| DE102019135564B4 (de) * | 2019-12-20 | 2022-05-19 | Johannes-Gutenberg-Universität Mainz | Verbindung für Smart-Drug-Delivery und pharmazeutisches Kit für duale nuklearmedizinisch-cytotoxische Theranostik |
| US20230096410A1 (en) | 2020-03-06 | 2023-03-30 | Sorrento Therapeutics, Inc. | Innate Immunity Killer Cells Targeting PSMA Positive Tumor Cells |
| WO2021250240A1 (en) | 2020-06-12 | 2021-12-16 | Orano | Diaza-18-crown-6 derivative useful for chelating radium, conjugate and radium chelate comprising the same, and uses thereof |
| US12521435B2 (en) | 2020-07-03 | 2026-01-13 | Case Western Reserve University | Photodynamic therapy composition |
| JP2023544201A (ja) | 2020-10-08 | 2023-10-20 | ターグイミューン セラピューティクス アクチエンゲゼルシャフト | がんを処置するための免疫療法 |
| US20230406847A1 (en) | 2020-11-12 | 2023-12-21 | Abx Advanced Biochemical Compounds Gmbh | Ligands of prostate specific membrane antigen (psma) containing heteroaromatic linker building blocks |
| WO2022108992A1 (en) * | 2020-11-17 | 2022-05-27 | The Johns Hopkins University | Prostate-specific membrane antigen (psma)-targeted prodrug for selective killing of cells expressing psma |
| CA3212963A1 (en) * | 2021-04-23 | 2022-10-27 | Reinier HERNANDEZ | Psma-targeting ligands with optimal properties for imaging and therapy |
| JP2024532521A (ja) | 2021-09-03 | 2024-09-05 | 晶核生物医藥科技（南京）有限公司 | ペプチド－尿素誘導体、それを含む医薬組成物、及びそれらの使用 |
| CN117980327A (zh) | 2021-11-03 | 2024-05-03 | 杭州多禧生物科技有限公司 | 抗体的特异性偶联 |
| WO2023079142A2 (en) | 2021-11-05 | 2023-05-11 | Targimmune Therapeutics Ag | Targeted linear conjugates comprising polyethyleneimine and polyethylene glycol and polyplexes comprising the same |
| US20250332265A1 (en) | 2021-11-09 | 2025-10-30 | Case Western Reserve University | Psma targeted conjugate compounds and uses thereof |
| AU2023347470A1 (en) | 2022-09-23 | 2025-04-10 | Nuclidium Ag | High-purity copper radiopharmaceutical compositions and diagnostic and therapeutic uses thereof |
| TW202426433A (zh) | 2022-09-23 | 2024-07-01 | 瑞士商紐利迪姆股份公司 | 成纖維細胞活化蛋白（ｆａｐ）抑制劑、ｆａｐ結合物及其診斷與治療用途 |
| JP2025537203A (ja) | 2022-11-07 | 2025-11-14 | ターグイミューン セラピューティクス アクチエンゲゼルシャフト | ポリエチレンイミンおよびポリエチレングリコールを含むｐｓｍａ標的化線状コンジュゲートならびにそれを含むポリプレックス |
| AU2023376544A1 (en) | 2022-11-07 | 2025-05-15 | Targimmune Therapeutics Ag | Polyplexes of nucleic acids and targeted conjugates comprising polyethyleneimine and polyethylene glycol |
| WO2024100046A1 (en) | 2022-11-07 | 2024-05-16 | Targimmune Therapeutics Ag | Targeted linear conjugates comprising polyethyleneimine and polyethylene glycol and polyplexes comprising the same |
| KR20250130683A (ko) | 2023-01-10 | 2025-09-02 | 썬 파마 어드밴스트 리서치 컴패니 리미티드 | 리간드-약물 접합체 |
| WO2024206482A1 (en) * | 2023-03-27 | 2024-10-03 | Yale University | Methods and kits for delivery of compounds into cells |
| US12324846B2 (en) | 2023-07-31 | 2025-06-10 | Curium Us Llc | [177LU] lutetium-PSMA IandT composition and dosimetry, kit, method of making, and method of using thereof |
| WO2025041103A1 (en) | 2023-08-23 | 2025-02-27 | Bright Peak Therapeutics Ag | Psma targeting ligands and methods of use |
| WO2025119908A1 (en) | 2023-12-06 | 2025-06-12 | Bracco Imaging Spa | Psma-targeting fluorescent probes |
| WO2025238236A1 (en) | 2024-05-16 | 2025-11-20 | Targimmune Therapeutics Ag | Polyplexes of nucleic acids and targeted conjugates comprising polyethyleneimine and polyethylene glycol |
Family Cites Families (232)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4713249A (en) | 1981-11-12 | 1987-12-15 | Schroeder Ulf | Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof |
| DE116208T1 (de) | 1982-12-07 | 1985-02-28 | Kyowa Hakko Kogyo Co., Ltd., Tokio/Tokyo | Mitomycin-analoge. |
| JPS60255789A (ja) | 1984-06-01 | 1985-12-17 | Kyowa Hakko Kogyo Co Ltd | マイトマイシン誘導体，その製造法および抗腫瘍剤 |
| US5266333A (en) | 1985-03-06 | 1993-11-30 | American Cyanamid Company | Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone |
| EP0280741B1 (en) | 1986-08-29 | 1994-12-07 | Kyowa Hakko Kogyo Kabushiki Kaisha | Mitomycin derivatives |
| AU634314B2 (en) | 1989-11-13 | 1993-02-18 | Green Cross Corporation, The | Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen |
| US5627165A (en) | 1990-06-13 | 1997-05-06 | Drug Innovation & Design, Inc. | Phosphorous prodrugs and therapeutic delivery systems using same |
| AU653565B2 (en) | 1990-12-21 | 1994-10-06 | Nikken Corporation | Raw sewage disposal apparatus and prefab for accomodating the same |
| US6291196B1 (en) | 1992-01-31 | 2001-09-18 | Research Corporation Technologies, Inc. | Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy |
| US7070782B1 (en) | 1992-11-05 | 2006-07-04 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen |
| US6569432B1 (en) | 1995-02-24 | 2003-05-27 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen and uses thereof |
| JP3538221B2 (ja) | 1993-11-19 | 2004-06-14 | 富士写真フイルム株式会社 | 定着濃厚液およびそれを用いたハロゲン化銀写真感光材料の処理方法 |
| US5417982A (en) | 1994-02-17 | 1995-05-23 | Modi; Pankaj | Controlled release of drugs or hormones in biodegradable polymer microspheres |
| US5866679A (en) | 1994-06-28 | 1999-02-02 | Merck & Co., Inc. | Peptides |
| US6946133B1 (en) | 1996-03-20 | 2005-09-20 | The United States Of America As Represented By The Department Of Health And Human Services | Prostate specific antigen oligo-epitope peptide |
| NZ331629A (en) | 1996-04-01 | 2000-04-28 | Epix Medical Inc | Bioactivated diagnostic imaging contrast agents |
| CA2251186A1 (en) | 1996-04-05 | 1997-10-16 | The Johns Hopkins University | A method of enriching rare cells |
| US5795877A (en) | 1996-12-31 | 1998-08-18 | Guilford Pharmaceuticals Inc. | Inhibitors of NAALADase enzyme activity |
| US5672592A (en) | 1996-06-17 | 1997-09-30 | Guilford Pharmaceuticals Inc. | Certain phosphonomethyl-pentanedioic acid derivatives thereof |
| US5902817A (en) | 1997-04-09 | 1999-05-11 | Guilford Pharmaceuticals Inc. | Certain sulfoxide and sulfone derivatives |
| US5863536A (en) | 1996-12-31 | 1999-01-26 | Guilford Pharmaceuticals Inc. | Phosphoramidate derivatives |
| US6054444A (en) | 1997-04-24 | 2000-04-25 | Guilford Pharmaceuticals Inc. | Phosphonic acid derivatives |
| US5998362A (en) | 1996-09-12 | 1999-12-07 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
| US6368598B1 (en) | 1996-09-16 | 2002-04-09 | Jcrt Radiation Oncology Support Services, Inc. | Drug complex for treatment of metastatic prostate cancer |
| US5962521A (en) | 1997-04-04 | 1999-10-05 | Guilford Pharmaceuticals Inc. | Hydroxamic acid derivatives |
| US6177404B1 (en) | 1996-10-15 | 2001-01-23 | Merck & Co., Inc. | Conjugates useful in the treatment of benign prostatic hyperplasia |
| US5948750A (en) | 1996-10-30 | 1999-09-07 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
| AU7019498A (en) | 1997-04-10 | 1998-10-30 | Diagnocure Inc. | Pca3, pca3 genes, and methods of use |
| US6127333A (en) | 1997-07-10 | 2000-10-03 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
| US6391305B1 (en) | 1997-09-10 | 2002-05-21 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
| US20020115596A1 (en) | 1997-10-27 | 2002-08-22 | Merk & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
| US20040081659A1 (en) | 1997-12-02 | 2004-04-29 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
| EA002745B1 (ru) | 1997-12-02 | 2002-08-29 | Мерк Энд Ко., Инк. | Конъюгаты, которые можно использовать при лечении рака предстательной железы |
| ZA9810974B (en) | 1997-12-02 | 1999-06-03 | Merck & Co Inc | Conjugates useful in the treatment of prostate cancer |
| AU2896399A (en) * | 1998-03-03 | 1999-09-20 | Exact Sciences Corporation | Purification and detection processes using reversible affinity electrophoresis |
| US20020103136A1 (en) | 1998-03-05 | 2002-08-01 | Dong-Mei Feng | Conjugates useful in the treatment of prostate cancer |
| US6232287B1 (en) | 1998-03-13 | 2001-05-15 | The Burnham Institute | Molecules that home to various selected organs or tissues |
| US6093382A (en) | 1998-05-16 | 2000-07-25 | Bracco Research Usa Inc. | Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
| US6833438B1 (en) | 1999-06-01 | 2004-12-21 | Agensys, Inc. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| EP2080802B1 (en) | 1998-06-01 | 2017-03-29 | Agensys, Inc. | Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| US20070020327A1 (en) | 1998-11-10 | 2007-01-25 | John Fikes | Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions |
| US6174858B1 (en) | 1998-11-17 | 2001-01-16 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
| US20030207808A1 (en) | 1999-02-18 | 2003-11-06 | Kinneret Savitzky | Novel nucleic acid and amino acid sequences |
| AU4063600A (en) | 1999-04-05 | 2000-10-23 | Merck & Co., Inc. | A method of treating cancer |
| CA2367787C (en) | 1999-04-28 | 2011-07-26 | Alan P. Kozikowski | Ligands for metabotropic glutamate receptors |
| US6528499B1 (en) | 2000-04-27 | 2003-03-04 | Georgetown University | Ligands for metabotropic glutamate receptors and inhibitors of NAALADase |
| AUPQ014799A0 (en) | 1999-05-04 | 1999-05-27 | Access Pharmaceuticals Australia Pty Limited | Amplification of folate-mediated targeting to tumor cells using polymers |
| US7166573B1 (en) | 1999-05-28 | 2007-01-23 | Ludwig Institute For Cancer Research | Breast, gastric and prostate cancer associated antigens and uses therefor |
| US20040146516A1 (en) | 1999-06-17 | 2004-07-29 | Utah Ventures Ii L.P. | Lumen-exposed molecules and methods for targeted delivery |
| US7361338B2 (en) | 1999-10-05 | 2008-04-22 | Agensys, Inc. | Methods to inhibit growth of prostate cancer cells |
| US6692724B1 (en) | 1999-10-25 | 2004-02-17 | Board Of Regents, The University Of Texas System | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| US6428785B1 (en) | 1999-10-28 | 2002-08-06 | Immunolytics Inc. | Method and composition for treating prostate cancer |
| CA2391534A1 (en) | 1999-11-15 | 2001-05-25 | Drug Innovation & Design, Inc. | Selective cellular targeting: multifunctional delivery vehicles |
| EP1267918A4 (en) | 2000-03-31 | 2007-06-27 | Purdue Research Foundation | METHOD OF TREATMENT USING LIGAND-IMMUNOGENE CONJUGATES |
| US20030072794A1 (en) | 2000-06-09 | 2003-04-17 | Teni Boulikas | Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes |
| US6933114B2 (en) | 2000-10-16 | 2005-08-23 | Gilead Sciences, Inc. | Nucleic acid ligands to the prostate specific membrane antigen |
| US20020132983A1 (en) | 2000-11-30 | 2002-09-19 | Junghans Richard P. | Antibodies as chimeric effector cell receptors against tumor antigens |
| US7468354B2 (en) | 2000-12-01 | 2008-12-23 | Genspera, Inc. | Tissue specific prodrugs |
| CA2434302A1 (en) * | 2001-01-08 | 2002-08-15 | Neorx Corporation | Therapeutic and diagnostic compounds, compositions, and methods |
| DE60214134T2 (de) | 2001-02-07 | 2007-07-19 | Beth Israel Deaconess Medical Center, Boston | Modifizierte psma-liganden und deren verwendung |
| AU2002306766A1 (en) | 2001-03-16 | 2002-10-03 | Johns Hopkins University School Of Medicine | Immune modulation by transduced hematopoietic stem cells expressing antigens and antigen-presenting cell regulatory molecules |
| WO2002085908A1 (en) | 2001-04-24 | 2002-10-31 | Purdue Research Foundation | Folate mimetics and folate-receptor binding conjugates thereof |
| EP1390077B1 (en) | 2001-05-02 | 2014-07-16 | Purdue Research Foundation | Treatment and diagnosis of macrophage mediated disease |
| US7109165B2 (en) | 2001-05-18 | 2006-09-19 | Sirna Therapeutics, Inc. | Conjugates and compositions for cellular delivery |
| US7514078B2 (en) | 2001-06-01 | 2009-04-07 | Cornell Research Foundation, Inc. | Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies |
| EP2277542B1 (en) | 2001-06-01 | 2014-04-16 | Cornell Research Foundation Inc. | Modified antibodies to prostrate-specific membrane antigen and uses thereof |
| US20040018203A1 (en) | 2001-06-08 | 2004-01-29 | Ira Pastan | Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates |
| ATE430935T1 (de) | 2001-06-21 | 2009-05-15 | Glycomimetics Inc | Nachweis und behandlung von prostatakrebs |
| US20030031677A1 (en) | 2001-06-25 | 2003-02-13 | Drug Innovation & Design, Incorporated | Exponential pattern recognition based cellular targeting, compositions, methods and anticancer applications |
| US7893223B2 (en) | 2001-07-17 | 2011-02-22 | Bracco Imaging S.P.A. | Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| WO2003018611A2 (en) | 2001-08-24 | 2003-03-06 | University Of Victoria Innovation And Development Corporation | Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| JP2005527474A (ja) | 2001-09-20 | 2005-09-15 | コーネル リサーチ ファンデーション インコーポレーテッド | 前立腺特異的膜抗原に特異的な結合剤を用いて、皮膚障害を治療するかまたは防止するための方法および組成物 |
| US20030232760A1 (en) | 2001-09-21 | 2003-12-18 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
| ATE451935T1 (de) | 2001-09-28 | 2010-01-15 | Purdue Research Foundation | Behandlungsverfahren mit liganden- immunogenkonjugaten |
| US20030215456A1 (en) | 2001-10-02 | 2003-11-20 | Sui-Long Yao | Method of treating cancer |
| US20030133927A1 (en) | 2001-10-10 | 2003-07-17 | Defeo-Jones Deborah | Conjugates useful in the treatment of prostate cancer |
| US20040058857A1 (en) | 2001-11-29 | 2004-03-25 | Siu-Long Yao | Method of treating cancer |
| US20070031438A1 (en) | 2001-12-10 | 2007-02-08 | Junghans Richard P | Antibodies as chimeric effector cell receptors against tumor antigens |
| WO2003060523A1 (en) | 2002-01-10 | 2003-07-24 | Johns Hopkins University | Imaging agents and methods of imaging naaladase of psma |
| US7344700B2 (en) | 2002-02-28 | 2008-03-18 | University Of Tennessee Research Corporation | Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy |
| CN1650033A (zh) | 2002-03-07 | 2005-08-03 | 约翰霍普金斯大学医学院 | 针对与癌症相关的表观遗传学沉默基因的基因组筛选 |
| US7534580B2 (en) | 2002-05-01 | 2009-05-19 | Ambrilia Biopharma Inc. | PSP94 diagnostic reagents and assays |
| SI2260875T1 (sl) | 2002-05-06 | 2014-07-31 | Endocyte, Inc. | Na folatni receptor usmerjena sredstva za slikanje |
| EP1504010B1 (en) | 2002-05-15 | 2009-03-25 | Endocyte, Inc. | Vitamin-mitomycin conjugates |
| US7767803B2 (en) | 2002-06-18 | 2010-08-03 | Archemix Corp. | Stabilized aptamers to PSMA and their use as prostate cancer therapeutics |
| JP2004064945A (ja) | 2002-07-31 | 2004-02-26 | Hitachi Koki Co Ltd | 回転体駆動装置 |
| CA2802205C (en) | 2002-07-31 | 2016-01-19 | Seattle Genetics, Inc. | Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| AR040956A1 (es) | 2002-07-31 | 2005-04-27 | Schering Ag | Nuevos conjugados de efectores, procedimientos para su preparacion y su uso farmaceutico |
| US7749968B2 (en) | 2002-08-05 | 2010-07-06 | The Johns Hopkins University | Peptides for targeting the prostate specific membrane antigen |
| WO2004015086A2 (en) | 2002-08-08 | 2004-02-19 | Johns Hopkins University | Enhancement of adenoviral oncolytic activity in prostate cells by modification of the e1a gene product |
| US8487128B2 (en) | 2002-11-26 | 2013-07-16 | Chs Pharma, Inc. | Protection of normal cells |
| WO2004058158A2 (en) | 2002-12-20 | 2004-07-15 | The Johns Hopkins University | Treatment of metastatic cancer with the b-subunit of shiga toxin |
| US20080008649A1 (en) | 2003-01-13 | 2008-01-10 | Bracco Imaging S.P.A. | Gastrin Releasing Peptide Compounds |
| US7226577B2 (en) | 2003-01-13 | 2007-06-05 | Bracco Imaging, S. P. A. | Gastrin releasing peptide compounds |
| CA2512867C (en) | 2003-01-27 | 2014-08-26 | Endocyte, Inc. | Vitamin receptor binding drug delivery conjugates |
| CA2514419A1 (en) | 2003-01-28 | 2004-08-12 | Proscan Rx Pharma Inc. | Prostate cancer diagnosis and treatment |
| EP1603392A2 (en) | 2003-03-07 | 2005-12-14 | The University Of Toledo | Paclitaxel hybrid derivatives |
| US7638122B2 (en) | 2003-03-07 | 2009-12-29 | University Of South Florida | Stat3 antagonists and their use as vaccines against cancer |
| US20070179100A1 (en) | 2003-04-09 | 2007-08-02 | Muthiah Manoharan | Protected monomers |
| ES2702942T3 (es) | 2003-04-17 | 2019-03-06 | Alnylam Pharmaceuticals Inc | Agentes de ARNi modificados |
| US7605182B2 (en) | 2003-05-01 | 2009-10-20 | Aposense Ltd. | Compounds that selectively bind to membranes of apoptotic cells |
| US8088387B2 (en) | 2003-10-10 | 2012-01-03 | Immunogen Inc. | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
| AU2004268932B2 (en) | 2003-06-13 | 2010-06-24 | Immunomedics, Inc. | D-amino acid peptides |
| US7232805B2 (en) | 2003-09-10 | 2007-06-19 | Inflabloc Pharmaceuticals, Inc. | Cobalamin conjugates for anti-tumor therapy |
| WO2005051315A2 (en) | 2003-11-24 | 2005-06-09 | The Regents Of The University Of California | On-demand cleavable linkers for radioconjugates for cancer imaging and therapy |
| FR2864546A1 (fr) | 2003-12-24 | 2005-07-01 | Assist Publ Hopitaux De Paris | Methode d'identification et de preparation de lymphocytes t regulateurs/suppresseurs, compositions et utilisations |
| WO2007010534A2 (en) | 2005-07-19 | 2007-01-25 | Spectrum Dynamics Llc | Imaging protocols |
| WO2006051531A2 (en) | 2004-11-09 | 2006-05-18 | Spectrum Dynamics Llc | Radioimaging |
| US8586932B2 (en) | 2004-11-09 | 2013-11-19 | Spectrum Dynamics Llc | System and method for radioactive emission measurement |
| DE102004004787A1 (de) | 2004-01-30 | 2005-08-18 | Schering Ag | Neue Effektor-Konjugate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
| AU2005216251B2 (en) | 2004-02-23 | 2011-03-10 | Genentech, Inc. | Heterocyclic self-immolative linkers and conjugates |
| WO2005094882A1 (en) | 2004-03-03 | 2005-10-13 | Millennium Pharmaceuticals, Inc. | Modified antibodies to prostate-specific membrane antigen and uses thereof |
| CN1926433A (zh) | 2004-03-03 | 2007-03-07 | 拜奥默里克斯公司 | 用于检测psa的可活化游离形式的方法及其用于诊断前列腺的良性病理学和前列腺的腺癌的用途 |
| DE602005008497D1 (de) | 2004-03-15 | 2008-09-11 | Roche Diagnostics Gmbh | Verwendung des BNP-Art und ANP-Art Peptiden für das Festsetzen der Gefahren von Herzgefäß- Komplikationen als Folge der Volumenüberlastung |
| EP1756166A4 (en) | 2004-04-19 | 2008-08-27 | Proscan Rx Pharma | DIAGNOSIS AND TREATMENT OF PROSTATE CANCER |
| US20060105975A1 (en) | 2004-04-19 | 2006-05-18 | Shannon Pendergrast | Aptamer-mediated intracellular delivery of therapeutic oligonucleotides |
| NZ550934A (en) * | 2004-05-19 | 2010-05-28 | Medarex Inc | Chemical linkers and conjugates thereof |
| RU2402548C2 (ru) | 2004-05-19 | 2010-10-27 | Медарекс, Инк. | Химические линкеры и их конъюгаты |
| US20080008719A1 (en) | 2004-07-10 | 2008-01-10 | Bowdish Katherine S | Methods and compositions for the treatment of prostate cancer |
| WO2006012527A1 (en) | 2004-07-23 | 2006-02-02 | Endocyte, Inc. | Bivalent linkers and conjugates thereof |
| ES2426816T3 (es) | 2004-08-04 | 2013-10-25 | Mentrik Biotech, Llc | Regiones Fc variantes |
| KR20070063526A (ko) | 2004-08-30 | 2007-06-19 | 뉴로메드 파머큐티칼즈 리미티드 | 칼슘 채널 차단제인 우레아 유도체 |
| US7713944B2 (en) | 2004-10-13 | 2010-05-11 | Isis Pharmaceuticals, Inc. | Oligomers comprising activated disulfides which bind to plasma proteins and their use for delivery to cells |
| ES2341268T3 (es) | 2004-10-27 | 2010-06-17 | Janssen Pharmaceutica Nv | Tiofenos trisubstituidos utilizados como antagonistas del receptor de la progesterona. |
| US8000773B2 (en) | 2004-11-09 | 2011-08-16 | Spectrum Dynamics Llc | Radioimaging |
| US20060140871A1 (en) | 2004-11-30 | 2006-06-29 | Sillerud Laurel O | Magnetic resonance imaging of prostate cancer |
| EP1844351A4 (en) | 2005-01-13 | 2017-07-05 | Biosensors International Group, Ltd. | Multi-dimensional image reconstruction and analysis for expert-system diagnosis |
| US20060155021A1 (en) | 2005-01-13 | 2006-07-13 | Lenges Christian P | Coating compositions containing rheology control agents |
| US7741510B2 (en) | 2005-01-13 | 2010-06-22 | E. I. Du Pont De Nemours And Company | Rheology control agents |
| WO2006083986A2 (en) | 2005-02-01 | 2006-08-10 | Government Of The U.S.A, As Represented By The Secretary Department Of Health & Human Services | Biomarkers for tissue status |
| WO2006093991A1 (en) | 2005-03-02 | 2006-09-08 | The Cleveland Clinic Foundation | Compounds which bind psma and uses thereof |
| EP1863828A4 (en) | 2005-03-07 | 2010-10-13 | Archemix Corp | STABILIZED APTAMERS FOR PSMA AND THEIR USE AS PROSTATE ACID THERAPEUTICS |
| US8088908B2 (en) | 2005-05-10 | 2012-01-03 | City Of Hope | Humanized anti-prostate stem cell antigen monoclonal antibody |
| KR101068612B1 (ko) | 2005-05-24 | 2011-09-30 | 휴마시스 주식회사 | 유사구조 단백질 비율 측정을 이용한 진단장치 |
| DE602006020867D1 (de) | 2005-06-14 | 2011-05-05 | Protox Therapeutics Inc | Verfahren zur behandlung oder prävention gutartiger prostatahyperplasie unter verwendung modifizierter porenbildender proteine |
| CN101287498B (zh) * | 2005-06-20 | 2013-03-27 | Psma开发有限公司 | Psma抗体-药物缀合物 |
| US7403088B2 (en) | 2005-06-29 | 2008-07-22 | Eaton Corporation | Handle apparatus and electrical switching apparartus employing the same |
| EP1904183B1 (en) | 2005-07-05 | 2014-10-15 | Purdue Research Foundation | Pharmaceutical composition for the treatment of osteoarthritis |
| US20070010014A1 (en) | 2005-07-06 | 2007-01-11 | General Electric Company | Compositions and methods for enhanced delivery to target sites |
| WO2007022493A2 (en) | 2005-08-19 | 2007-02-22 | Endocyte, Inc. | Ligand conjugates of vinca alkaloids, analogs, and derivatives |
| RU2470668C2 (ru) | 2005-08-19 | 2012-12-27 | Эндосайт, Инк. | Конъюгаты лиганда с несколькими лекарственными средствами |
| EP2015781A4 (en) | 2005-09-12 | 2009-12-23 | Univ Johns Hopkins | COMPOSITIONS HAVING ANTIANGIOGENIC ACTIVITY AND USES THEREOF |
| JP5368099B2 (ja) | 2005-10-07 | 2013-12-18 | ゲルベ | ガリウムと錯体形成することが可能なシグナル部分にカップリングされた、生物学的標的の認識のための部分を含んでなる化合物 |
| CA2670355A1 (en) | 2005-11-21 | 2008-04-24 | Medivas, Llc | Polymer particles for delivery of macromolecules and methods of use |
| DK1951316T3 (en) | 2005-11-23 | 2015-08-31 | Ventana Med Syst Inc | molecular conjugate |
| US8258256B2 (en) | 2006-01-05 | 2012-09-04 | The Johns Hopkins University | Compositions and methods for the treatment of cancer |
| US7635682B2 (en) | 2006-01-06 | 2009-12-22 | Genspera, Inc. | Tumor activated prodrugs |
| CN101443340B (zh) | 2006-03-14 | 2013-12-04 | 癌靶技术有限责任公司 | 前列腺特异性膜抗原的拟肽抑制剂、含该拟肽抑制剂的化合物及用法 |
| ATE509033T1 (de) | 2006-03-20 | 2011-05-15 | Univ California | Manipulierte anti-prostatastammzellenantigen (psca)-antikörper für krebs-targeting |
| US20070225213A1 (en) | 2006-03-23 | 2007-09-27 | Kosak Matthew K | Nucleic acid carriers for delivery of therapeutic agents |
| CA2648099C (en) | 2006-03-31 | 2012-05-29 | The Brigham And Women's Hospital, Inc | System for targeted delivery of therapeutic agents |
| US20140314864A1 (en) | 2006-03-31 | 2014-10-23 | Massachusetts Institute Of Technology | System for Targeted Delivery of Therapeutic Agents |
| US7842280B2 (en) * | 2006-09-06 | 2010-11-30 | Case Western Reserve University | Flexibly labeling peptides |
| JP2010509570A (ja) | 2006-11-03 | 2010-03-25 | パーデュー・リサーチ・ファウンデーション | エクスビボフローサイトメトリーの方法および装置 |
| DK2097111T3 (en) | 2006-11-08 | 2015-08-24 | Molecular Insight Pharm Inc | Heterodimers of glutamic acid |
| CA2670749A1 (en) | 2006-12-05 | 2008-06-12 | Landec Corporation | Drug delivery |
| US8507434B2 (en) | 2007-01-03 | 2013-08-13 | The Johns Hopkins University | Peptide modulators of angiogenesis and use thereof |
| CA2675202C (en) | 2007-01-11 | 2014-09-16 | Immunomedics, Inc. | Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules |
| US20080214436A1 (en) | 2007-01-26 | 2008-09-04 | City Of Hope | Methods and compositions for the treatment of cancer or other diseases |
| AU2008213702B2 (en) | 2007-02-07 | 2014-04-24 | Purdue Research Foundation | Positron emission tomography imaging method |
| US20100104626A1 (en) | 2007-02-16 | 2010-04-29 | Endocyte, Inc. | Methods and compositions for treating and diagnosing kidney disease |
| AU2008224988A1 (en) | 2007-03-14 | 2008-09-18 | Endocyte, Inc. | Binding ligand linked drug delivery conjugates of tubulysins |
| EP2155231B1 (en) | 2007-04-10 | 2012-08-08 | The Johns Hopkins University | Imaging and therapy of virus-associated tumors |
| RU2523909C2 (ru) | 2007-06-25 | 2014-07-27 | Эндосайт, Инк. | Конъюгаты, содержащие гидрофильные спейсеры линкеров |
| CN101784192B (zh) | 2007-06-26 | 2015-03-18 | 约翰·霍普金斯大学 | 标记的前列腺特异性膜抗原(psma)的抑制子、生物学评估及作为成像试剂的用途 |
| GB0723246D0 (en) | 2007-07-03 | 2008-01-09 | Barton Michelle | p53 modulator |
| WO2009029342A2 (en) | 2007-07-13 | 2009-03-05 | The Johns Hopkins University | B7-dc variants |
| CA2695385A1 (en) | 2007-07-31 | 2009-02-05 | Atul Bedi | Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders |
| PT2187965T (pt) | 2007-08-17 | 2020-01-17 | Purdue Research Foundation | Conjugados ligando-ligante de ligação a psma e métodos para utilização |
| WO2009035942A1 (en) | 2007-09-13 | 2009-03-19 | Chemimage Corporation | Distinguishing between renal oncocytoma and chromophobe renal cell carcinoma using raman molecular imaging |
| EA023175B1 (ru) | 2007-09-28 | 2016-05-31 | Бинд Терапьютикс, Инк. | Таргетирование раковых клеток с использованием наночастиц |
| US9187521B2 (en) | 2007-10-25 | 2015-11-17 | Endocyte, Inc. | Tubulysins and processes for preparing |
| US8450290B2 (en) | 2007-11-26 | 2013-05-28 | Enzon Pharmaceuticals, Inc. | Methods for treating androgen receptor dependent disorders including cancers |
| WO2009070302A1 (en) | 2007-11-30 | 2009-06-04 | The Johns Hopkins University | Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancer |
| US8507455B2 (en) | 2007-12-04 | 2013-08-13 | Alnylam Pharmaceuticals, Inc. | Folate conjugates |
| WO2009076434A1 (en) | 2007-12-12 | 2009-06-18 | Molecular Insight Pharmaceuticals, Inc. | Inhibitors of integrin vla-4 |
| US8562945B2 (en) | 2008-01-09 | 2013-10-22 | Molecular Insight Pharmaceuticals, Inc. | Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof |
| AU2009204133B2 (en) | 2008-01-09 | 2014-04-10 | Molecular Insight Pharmaceuticals, Inc. | Inhibitors of carbonic anhydrase IX |
| ITTO20080313A1 (it) | 2008-04-22 | 2009-10-23 | Marco Colombatti | Anticorpo monoclonale isolato o suo frammento legante l'antigene specifico di membrana della prostata, suoi coniugati e suoi usi |
| EP2990487A1 (en) | 2008-05-08 | 2016-03-02 | Asuragen, INC. | Compositions and methods related to mirna modulation of neovascularization or angiogenesis |
| US8852630B2 (en) | 2008-05-13 | 2014-10-07 | Yale University | Chimeric small molecules for the recruitment of antibodies to cancer cells |
| JP5746615B2 (ja) | 2008-05-13 | 2015-07-08 | エール ユニヴァーシティ | 癌細胞への抗体の動員のためのキメラ小分子 |
| JP6363320B2 (ja) | 2008-06-16 | 2018-07-25 | ファイザー・インク | 薬剤を装填したポリマーナノ粒子及びその製造方法と使用方法 |
| LT3222615T (lt) | 2008-08-01 | 2022-08-25 | The Johns Hopkins University | Psma surišantys agentai ir jų naudojimas |
| AU2009281732A1 (en) | 2008-08-15 | 2010-02-18 | Georgetown University | Na channels, disease, and related assays and compositions |
| DK2326350T3 (da) | 2008-09-08 | 2013-12-16 | Psma Dev Company L L C | Forbindelser til at dræbe psma-udtrykkende, taxanresistente cancerceller |
| EP2166021A1 (en) | 2008-09-16 | 2010-03-24 | Ganymed Pharmaceuticals AG | Monoclonal antibodies for treatment of cancer |
| EP2349274B1 (en) | 2008-09-17 | 2025-04-09 | Endocyte, Inc. | Folate receptor binding conjugates of antifolates |
| WO2010045598A2 (en) | 2008-10-17 | 2010-04-22 | Purdue Research Foundation | Psma binding ligand-linker conjugates and methods for using |
| CA2745955C (en) | 2008-12-05 | 2017-05-23 | Molecular Insight Pharmaceuticals, Inc. | Technetium- and rhenium- bis (heteroaryl) complexes and methods of use thereof for inhibiting psma |
| WO2010065906A2 (en) | 2008-12-05 | 2010-06-10 | Molecular Insight Pharmaceuticals, Inc. | Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer |
| ES2712732T3 (es) | 2009-02-17 | 2019-05-14 | Cornell Res Foundation Inc | Métodos y kits para el diagnóstico de cáncer y la predicción de valor terapéutico |
| EP2408465A4 (en) | 2009-03-17 | 2012-11-28 | Univ Johns Hopkins | METHODS AND COMPOSITIONS FOR CANCER SCREENING |
| HRP20240952T1 (hr) | 2009-03-19 | 2024-10-11 | The Johns Hopkins University | Spojevi koji ciljaju psma i njihova uporaba |
| BR112012000210A2 (pt) | 2009-06-15 | 2019-09-24 | Molecular Insight Pharm Inc | processo para a produção de heterodímeoros de ácido glutâmico. |
| NZ598145A (en) | 2009-07-31 | 2014-10-31 | Endocyte Inc | Folate-targeted diagnostics and treatment |
| US8394922B2 (en) | 2009-08-03 | 2013-03-12 | Medarex, Inc. | Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
| US8313128B2 (en) | 2009-08-20 | 2012-11-20 | Rhoost, Llc. | Safety locking mechanism for doors |
| US8685891B2 (en) | 2009-08-27 | 2014-04-01 | Nuclea Biotechnologies, Inc. | Method and assay for determining FAS expression |
| EP3135302A1 (en) | 2009-12-02 | 2017-03-01 | Imaginab, Inc. | J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use |
| US8357401B2 (en) | 2009-12-11 | 2013-01-22 | Bind Biosciences, Inc. | Stable formulations for lyophilizing therapeutic particles |
| CA2788907A1 (en) | 2010-02-04 | 2011-08-11 | Radius Health, Inc. | Selective androgen receptor modulators |
| WO2011106639A1 (en) | 2010-02-25 | 2011-09-01 | Purdue Research Foundation | Psma binding ligand-linker conjugates and methods for using |
| US9951324B2 (en) | 2010-02-25 | 2018-04-24 | Purdue Research Foundation | PSMA binding ligand-linker conjugates and methods for using |
| CN101863924B (zh) | 2010-05-17 | 2012-06-27 | 北京师范大学 | 99mTc标记肼基烟酰胺基-二氧辛酰-叶酸配合物及制备方法 |
| JP6275484B2 (ja) | 2010-12-06 | 2018-02-07 | モレキュラ インサイト ファーマシューティカルズ インコーポレイテッド | Ｐｓｍａ標的化デンドリマー |
| WO2012166923A2 (en) | 2011-05-31 | 2012-12-06 | Bind Biosciences | Drug loaded polymeric nanoparticles and methods of making and using same |
| PL2739316T3 (pl) | 2011-08-05 | 2019-09-30 | Molecular Insight Pharmaceuticals, Inc. | Radioznakowane inhibitory antygenu błonowego specyficznego dla prostaty |
| US10011632B2 (en) | 2011-08-22 | 2018-07-03 | Siemens Medical Solutions Usa, Inc. | PSMA imaging agents |
| US9629918B2 (en) | 2012-02-29 | 2017-04-25 | Purdue Research Foundation | Folate receptor alpha binding ligands |
| WO2014062697A2 (en) | 2012-10-16 | 2014-04-24 | Endocyte, Inc. | Drug delivery conjugates containing unnatural amino acids and methods for using |
| US20140107316A1 (en) | 2012-10-16 | 2014-04-17 | Endocyte, Inc. | Drug delivery conjugates containing unnatural amino acids and methods for using |
| JP6892218B2 (ja) | 2012-11-15 | 2021-06-23 | エンドサイト・インコーポレイテッドＥｎｄｏｃｙｔｅ， Ｉｎｃ． | 薬物送達結合体およびｐｓｍａ発現細胞によって引き起こされる疾患の治療方法 |
| US20140154702A1 (en) | 2012-11-30 | 2014-06-05 | Endocyte, Inc. | Methods For Treating Cancer Using Combination Therapies |
| US9567340B2 (en) | 2012-12-21 | 2017-02-14 | Medimmune Limited | Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases |
| CN104936622B (zh) | 2012-12-28 | 2019-05-28 | 塔弗达治疗有限公司 | 包封在颗粒中的靶向缀合物及其制剂 |
| WO2014127365A1 (en) | 2013-02-15 | 2014-08-21 | Case Western Reserve University | Psma ligands and uses thereof |
| US20140249315A1 (en) | 2013-03-01 | 2014-09-04 | Endocyte, Inc. | Processes for preparing tubulysins |
| US20170232119A1 (en) * | 2013-03-15 | 2017-08-17 | Purdue Research Foundation | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors |
| US10406246B2 (en) | 2013-10-17 | 2019-09-10 | Deutsches Kresbsforschungszentrum | Double-labeled probe for molecular imaging and use thereof |
| US20150110814A1 (en) | 2013-10-18 | 2015-04-23 | Psma Development Company, Llc | Combination therapies with psma ligand conjugates |
| EP3415489A1 (en) | 2013-10-18 | 2018-12-19 | Deutsches Krebsforschungszentrum | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
| BR112016010927A2 (pt) | 2013-11-14 | 2017-08-08 | Endocyte Inc | Conjugado de fórmula |
| CA2950892C (en) | 2014-05-06 | 2023-10-24 | The Johns Hopkins University | Metal/radiometal-labeled psma inhibitors for psma-targeted imaging and radiotherapy |
| ES2912753T3 (es) | 2014-08-24 | 2022-05-27 | Max Planck Gesellschaft Zur Foerderung Der Wss | Método para la producción de ésteres activos marcados con 18F y su aplicación ejemplificada por la preparación de un marcador de PET específico de PSMA |
| JP2017530109A (ja) | 2014-09-08 | 2017-10-12 | モレキュラ インサイト ファーマシューティカルズ インコーポレイテッド | 前立腺癌についてのｐｓｍａを標的とした放射性核種治療中の臓器の保護 |
| WO2016183131A1 (en) * | 2015-05-11 | 2016-11-17 | Purdue Research Foundation | Ligand ionophore conjugates |
| US10842887B2 (en) * | 2015-09-09 | 2020-11-24 | On Target Laboratories, LLC | PSMA-targeted NIR dyes and their uses |
| US9808538B2 (en) * | 2015-09-09 | 2017-11-07 | On Target Laboratories, LLC | PSMA-targeted NIR dyes and their uses |
| FR3043970B1 (fr) | 2015-11-25 | 2019-06-21 | Medtech Sa | Systeme mecanique de stabilisation au sol pour vehicules a roulettes |
| JP6806471B2 (ja) | 2016-06-16 | 2021-01-06 | キヤノン株式会社 | 焦点検出装置及び方法、及び撮像装置 |
| WO2018049132A1 (en) * | 2016-09-09 | 2018-03-15 | On Target Laboratories, LLC | Psma-targeted nir dyes and their uses |
-
2008
- 2008-08-15 PT PT87980207T patent/PT2187965T/pt unknown
- 2008-08-15 WO PCT/US2008/073375 patent/WO2009026177A1/en not_active Ceased
- 2008-08-15 EP EP08798020.7A patent/EP2187965B1/en not_active Revoked
- 2008-08-15 CN CN201510221167.5A patent/CN104873982A/zh active Pending
- 2008-08-15 US US12/673,931 patent/US9193763B2/en active Active
- 2008-08-15 EP EP20216457.0A patent/EP3858347A3/en active Pending
- 2008-08-15 CN CN200880111794.1A patent/CN102014956B/zh active Active
- 2008-08-15 ES ES08798020T patent/ES2768224T3/es active Active
- 2008-08-15 EP EP20196755.1A patent/EP3831380A3/en not_active Withdrawn
- 2008-08-15 EP EP19188077.2A patent/EP3656403B1/en active Active
- 2008-08-15 CA CA2696627A patent/CA2696627C/en active Active
- 2008-08-15 EP EP24202375.2A patent/EP4464384A3/en active Pending
- 2008-08-15 NZ NZ583931A patent/NZ583931A/en unknown
- 2008-08-15 SI SI200832106T patent/SI2187965T1/sl unknown
- 2008-08-15 EP EP18175078.7A patent/EP3388086B1/en active Active
- 2008-08-15 JP JP2010521210A patent/JP2010536790A/ja active Pending
- 2008-08-15 DK DK08798020.7T patent/DK2187965T3/da active
- 2008-08-15 PL PL08798020T patent/PL2187965T3/pl unknown
- 2008-08-15 EP EP20196752.8A patent/EP3838298B1/en active Active
- 2008-08-15 HU HUE08798020A patent/HUE047200T2/hu unknown
- 2008-08-15 AU AU2008289108A patent/AU2008289108C1/en active Active
- 2008-08-15 NZ NZ600085A patent/NZ600085A/en unknown
-
2010
- 2010-02-17 IL IL203998A patent/IL203998A/en active IP Right Grant
-
2013
- 2013-03-14 US US13/826,079 patent/US8907058B2/en active Active
-
2014
- 2014-06-18 JP JP2014125603A patent/JP5902237B2/ja active Active
-
2015
- 2015-11-23 US US14/794,482 patent/US10046054B2/en active Active
-
2016
- 2016-01-15 HK HK16100437.3A patent/HK1212588A1/zh unknown
- 2016-03-09 JP JP2016046076A patent/JP2016153410A/ja active Pending
-
2017
- 2017-05-26 US US15/606,913 patent/US10406240B2/en active Active
- 2017-11-21 JP JP2017223872A patent/JP6596479B2/ja active Active
-
2018
- 2018-04-20 US US15/959,110 patent/US10624969B2/en active Active
- 2018-05-25 US US15/990,083 patent/US10517956B2/en active Active
- 2018-05-25 US US15/990,152 patent/US10828282B2/en active Active
- 2018-05-25 US US15/990,095 patent/US10624970B2/en active Active
- 2018-05-25 US US15/990,111 patent/US10485878B2/en active Active
- 2018-05-25 US US15/990,144 patent/US10624971B2/en active Active
- 2018-05-25 US US15/990,136 patent/US10646581B2/en active Active
- 2018-05-25 JP JP2018100343A patent/JP6625690B2/ja active Active
- 2018-06-04 US US15/997,451 patent/US10517957B2/en active Active
-
2019
- 2019-07-10 US US16/507,713 patent/US11298341B2/en active Active
- 2019-09-30 JP JP2019179190A patent/JP6838118B2/ja active Active
- 2019-12-17 US US16/717,753 patent/US20200188523A1/en not_active Abandoned
-
2020
- 2020-01-22 US US16/749,827 patent/US11083710B2/en active Active
- 2020-01-22 US US16/749,896 patent/US20200297701A1/en not_active Abandoned
- 2020-05-07 US US16/869,268 patent/US11504357B2/en active Active
- 2020-10-30 US US17/086,063 patent/US11717514B2/en active Active
-
2021
- 2021-02-10 JP JP2021019732A patent/JP7079355B2/ja active Active
- 2021-06-25 US US17/359,277 patent/US11369590B2/en active Active
- 2021-06-25 US US17/358,726 patent/US12496292B2/en active Active
- 2021-06-25 US US17/359,314 patent/US11318121B2/en active Active
-
2022
- 2022-01-11 US US17/573,304 patent/US20230000836A1/en active Pending
- 2022-05-19 JP JP2022082105A patent/JP7609824B2/ja active Active
- 2022-11-21 US US17/991,013 patent/US20230293497A1/en active Pending
-
2023
- 2023-03-09 US US18/181,487 patent/US20230346752A1/en active Pending
-
2024
- 2024-06-12 JP JP2024095014A patent/JP2024117783A/ja active Pending
- 2024-12-11 US US18/977,274 patent/US20250108039A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020073472A5 (enExample) | ||
| Lattuada et al. | The synthesis and application of polyamino polycarboxylic bifunctional chelating agents | |
| JP2021073272A5 (enExample) | ||
| JP2010521485A5 (enExample) | ||
| JPWO2020122034A5 (enExample) | ||
| JP2016153410A5 (enExample) | ||
| JP6966741B2 (ja) | 放射性標識薬剤 | |
| JP2013500304A5 (enExample) | ||
| JP2018058847A5 (enExample) | ||
| JP2019172710A5 (enExample) | ||
| JP2009500431A5 (enExample) | ||
| JP2018502131A5 (enExample) | ||
| JP7650228B2 (ja) | 官能化シクロオクテンを調製するためのプロセス | |
| JPWO2008010463A1 (ja) | コンブレタスタチン類の高分子結合体 | |
| JP2003531835A5 (enExample) | ||
| CA2405469A1 (en) | Integrin binding peptide derivatives | |
| JP2012521201A5 (enExample) | ||
| JPWO2013081091A1 (ja) | 非特異的腎集積が低減された放射性標識ポリペプチド作製用薬剤 | |
| JP2018508492A5 (enExample) | ||
| JP2013531659A5 (enExample) | ||
| JP2023038235A5 (enExample) | ||
| JP2017534675A5 (enExample) | ||
| JP2010536714A5 (enExample) | ||
| JP2006508972A5 (enExample) | ||
| JP2013544254A5 (enExample) |